根据基因表达和临床信息确定脏清细胞癌的预后
Xiong Zou1, Xi Chen1, Jianjun Yang1
1Department of Urology, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
Frontiers in molecular biosciences
|September 5, 2025
概括
这项研究确定了四个关键基因 (BASP1,CCL8,FCGR1B,FKBP11) 以改善脏清细胞癌 (KIRC) 的预后评估. 这些发现有助于医生个性化KIRC治疗策略.
科学领域:
- 癌症学
- 免疫学
- 生物信息学
背景情况:
- 清细胞癌 (KIRC) 的预后异质,超过目前的分期系统能力.
- 对KIRC患者的评估和个性化治疗需要改进的预后工具.
研究的目的:
- 通过综合的多组数据,为KIRC开发可靠的预测模型.
- 确定与KIRC预后和免疫微环境相关的关键基因.
主要方法:
- 基于免疫基因集的KIRC数据集 (GSE40435,GSE46699) 的免疫分组.
- 对TCGA KIRC数据 (RNA-seq,临床,突变) 与GEO数据的分析.
- 使用定量实时PCR (qPCR) 验证预后相关基因 (PRG).
主要成果:
- 在KIRC免疫亚型中存在不同的免疫微环境和遗传特征.
- 已确定四个基因 (BASP1,CCL8,FCGR1B,FKBP11) 用于KIRC风险分层.
- 开发了一个结合基因表达和临床数据的预后模型;在KIRC中增加了BASP1,FCGR1B,FKBP11.
结论:
- 开发的模型可以帮助临床医生评估KIRC预后.
- 这种工具可为KIRC患者提供及时和个性化的治疗修改.
相关概念视频
The Retinoblastoma Gene
4.2K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
Cancer Survival Analysis
445
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
445


